Cargando…
Promoter DNA methylation analysis reveals a combined diagnosis of CpG-based biomarker for prostate cancer
BACKGROUND: Prostate cancer (PCa) is the most common tumor in elderly men. However, the specificity and sensitivity of serum prostate-specific antigen levels in PCa diagnosis are controversial. This study aims to reveal a novel diagnosis biomarker in PCa. MATERIALS AND METHODS: The differential meth...
Autores principales: | Tang, Yuanyuan, Jiang, Shusuan, Gu, Yinmin, Li, Weidong, Mo, Zengnan, Huang, Yuanjie, Li, Tianyu, Hu, Yanling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601644/ https://www.ncbi.nlm.nih.gov/pubmed/28938548 http://dx.doi.org/10.18632/oncotarget.16437 |
Ejemplares similares
-
Promoter DNA methylation analysis reveals a novel diagnostic CpG-based biomarker and RAB25 hypermethylation in clear cell renel cell carcinoma
por: Gu, Yinmin, et al.
Publicado: (2017) -
Functional analysis implicating the SNP rs61552325 in ERBB2 as an effector for androgen-insensitive prostate cancer cell invasion
por: Xin, Xianxiang, et al.
Publicado: (2017) -
Preservation of methylated CpG dinucleotides in human CpG islands
por: Panchin, Alexander Y., et al.
Publicado: (2016) -
Factors to preserve CpG-rich sequences in methylated CpG islands
por: Miyahara, Hiroki, et al.
Publicado: (2015) -
The Effects of O(6)-methyl Guanine DNA-methyl Transferase Promotor Methylation and CpG1, CpG2, CpG3 and CpG4 Methylation on Treatment Response and their Prognostic Significance in Patients with Glioblastoma
por: Yildiz, OG, et al.
Publicado: (2020)